Skip to main content
    S

    Sanofi ADR (SNY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $47.53
    -0.86 (-1.78%)

    Market Cap: $116.15B

    Last updated: Nov 17, 2026 at 4:19 PM ET

    Sanofi ADR (SNY) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Sanofi ADR (SNY) has a market cap of $116.15B. Revenue grew 20.98% over the last 12 months from the 12 months before. Its dividend yield is 5.10%.

    Total Valuation

    Market Cap$116.15B
    Latest price (Nov 17, 2026)$47.53

    Key Dates

    The last ex-dividend date was May 4, 2026.

    Last Earnings DateOct 30, 2026
    Last Ex-Dividend DateMay 4, 2026
    Last Payment DateJun 3, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.28% in the quarter ended Sep 30, 2026 and shrank 2.14% a year over 2 years.

    Shares Outstanding2.40B
    Shares Change (YoY)-2.75%
    Shares Change (QoQ)+0.28%
    Share Count Growth (2Y CAGR)-2.14%

    Valuation Ratios

    Sales and book value multiples are 1.9x and 1.4x. Its year-end P/S ranged from 2.2x to 3.0x from 2016 to 2025.

    P/S Ratio1.9x
    P/B Ratio1.4x
    P/TBV Ratio19.2x

    Valuation history and multiples

    Price Statistics

    The stock is down 3.75% over 52 weeks and trades 10.92% above its 50-day average.

    Beta (1Y)0.26
    52-Week Change-3.75%
    1-Month Change+20.12%
    3-Month Change+3.71%
    6-Month Change+9.14%
    5-Year Change-12.08%
    10-Year Change+14.01%
    Total Return (1Y)+1.16%
    Total Return (3Y CAGR)+5.11%
    Total Return (5Y CAGR)+3.27%
    Return vs SPY (1Y)-12.49%
    Max Drawdown (1Y)-20.23%
    Max Drawdown (3Y)-27.40%
    Sharpe Ratio (1Y)-0.04
    Correlation with SPY (1Y)0.16
    50-Day Average$42.85
    200-Day Average$43.61
    52-Week Range$39.07 to $48.98
    RSI (14 Days)67.3
    Average Volume (20 Days)4.32M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.12x current liabilities, and total debt is 0.25x shareholder equity.

    Current Ratio1.12x
    Quick Ratio0.27x
    Debt / Equity0.25x
    Debt / EBITDA1.14x
    Interest Coverage12.17x

    Returns and Efficiency

    Return on invested capital is 7.58% over the last 12 months, against a 5-year average of 6.82%.

    Return on Equity (ROE)5.74%
    Return on Assets (ROA)3.21%
    Return on Invested Capital (ROIC)7.58%
    Return on Capital Employed (ROCE)9.53%
    ROE (5Y Average)9.13%
    ROA (5Y Average)5.28%
    ROIC (5Y Average)6.82%
    Asset Turnover0.39x
    Inventory Turnover0.55x
    Receivables Turnover10.77x
    Cash Conversion Cycle47 days

    Taxes

    Income tax took 29.06% of pretax income over the last 12 months.

    Income Tax (TTM)EUR 1.72B
    Effective Tax Rate29.06%

    Scores

    SNY has an Altman Z-Score of 1.73, in the distress zone below 1.81, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score1.73
    Altman Z ZoneDistress
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was EUR 50.98B over the last 12 months.

    RevenueEUR 50.98B
    Revenue Growth (YoY)+20.98%
    Gross ProfitEUR 37.56B
    Operating IncomeEUR 8.32B
    Pretax IncomeEUR 5.91B
    Net IncomeEUR 4.18B
    EBITDAEUR 15.56B
    EBITEUR 9.58B

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 55.94% of the EUR 130.29B in total assets.

    Working CapitalEUR 3.44B
    Shareholder EquityEUR 72.88B
    Tangible Book ValueEUR 5.25B
    Total AssetsEUR 130.29B
    Total LiabilitiesEUR 57.05B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After EUR 4.00B of capital spending, operating cash flow left EUR 10.42B of free cash flow.

    Operating Cash FlowEUR 14.42B
    Capital ExpendituresEUR 4.00B
    Free Cash FlowEUR 10.42B
    Depreciation and AmortizationEUR 6.33B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 16.32%, against a 5-year average of 19.89%.

    Gross Margin73.68%
    Operating Margin16.32%
    Pretax Margin11.59%
    Net Margin8.19%
    EBITDA Margin30.52%
    EBIT Margin18.79%
    FCF Margin20.43%
    Gross Margin (5Y Average)70.27%
    Operating Margin (5Y Average)19.89%
    Net Margin (5Y Average)15.76%

    Growth

    Revenue grew 4.82% a year over 3 years.

    Revenue Growth (3Y CAGR)+4.82%
    Revenue Growth (5Y CAGR)+4.57%
    FCF Growth (3Y CAGR)-4.67%
    FCF Growth (5Y CAGR)+6.21%
    Operating Income Growth (3Y CAGR)-1.89%

    Revenue and profit by year

    Dividends and Yields

    SNY pays out 35.11% of earnings as dividends.

    Dividend Per Share (Annual)$2.42
    Dividend Yield5.10%
    Payment ScheduleAnnual
    Dividend Growth (3Y CAGR)+7.91%
    Dividend Growth (5Y CAGR)+4.60%
    Payout Ratio35.11%

    Full dividend history

    Peer Position

    Against 12 similar companies, SNY has the lowest P/S and the 2nd highest dividend yield.

    P/S Ratio1.9x vs 4.9x median
    ROIC7.58% vs 13.95% median
    Revenue Growth (Trailing 4 Quarters, YoY)+20.98% vs +5.31% median
    Dividend Yield5.10% vs 2.37% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About SNY

    What is SNY's market cap?

    Sanofi ADR has a market cap of $116.15B.

    How many shares of SNY are outstanding?

    Sanofi ADR has 2.40B shares outstanding. The count is down 2.75% from a year earlier.

    Does SNY pay a dividend?

    Yes. Sanofi ADR pays $2.42 a share a year, a dividend yield of 5.10%.